
Pacira BioSciences PCRX
$ 26.19
-1.21%
Quarterly report 2025-Q3
added 11-06-2025
Pacira BioSciences P/S Ratio 2011-2025 | PCRX
Annual P/S Ratio Pacira BioSciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.13 | 6.56 | 4.24 | 4.95 | 5.06 | 4.91 | 8.72 | 19.2 | 25.7 | 15.2 | 11.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.7 | 4.24 | 10.1 |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.2 | 0.42 % | $ 129 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.67 | 0.19 % | $ 1.39 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 4.32 | -3.79 % | $ 86.3 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 12.28 | -1.17 % | $ 629 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | $ 21.57 | -0.12 % | $ 2.05 B | ||
|
Evolus
EOLS
|
3.33 | $ 6.67 | -3.33 % | $ 414 M | ||
|
Harrow Health
HROW
|
2.67 | $ 50.64 | 1.09 % | $ 1.65 B | ||
|
China Pharma Holdings
CPHI
|
1 | $ 1.27 | -1.17 % | $ 22.2 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.71 | -4.47 % | $ 402 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 5.22 | -1.14 % | $ 687 M | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 7.15 | -0.69 % | $ 2.61 B | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 3.66 | 1.25 % | $ 4.54 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.02 | -2.31 % | $ 56.5 M | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 0.82 | -5.16 % | $ 19.1 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.73 | -0.29 % | $ 3.37 M | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Veru
VERU
|
6.39 | $ 2.2 | -8.33 % | $ 297 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
0.905 | $ 13.87 | 0.4 % | $ 1.91 B | ||
|
ProPhase Labs
PRPH
|
1.06 | $ 0.45 | -13.46 % | $ 7.13 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 1.46 | -14.41 % | $ 6.3 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
0.434 | $ 9.56 | -3.82 % | $ 679 M | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.62 | 6.08 % | $ 29.7 M | ||
|
Tilray
TLRY
|
1.9 | $ 9.33 | -2.81 % | $ 5.77 B | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 1.67 | -4.02 % | $ 17.4 M |